PMID 14500546
The analysis also includes tirzepatide (Mounjaro and Zepbound), which is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist (and classified under A10BX or other blood glucose lowering drugs, excl
Meanwhile, NNMTi preserves lean body mass: it reduces fat accumulation without causing muscle loss, which is crucial for maintaining basal metabolism and preventing weight regain after dieting.These in vivo findings fully validate the efficacy and safety of NNMTi in obesity intervention, laying a solid foundation for its subsequent clinical research and drug development
This contributes to the occurrence of l-dopa-related complications (LDRCs), notably motor fluctuations and l-dopa-induced dyskinesia, whose severity is associated with nigral denervation 2,3,4,5,6,7,8,9